[Cyclosporine A in dermatology].

Area of Science:

• Immunology
• Dermatology
• Pharmacology

Context:

• Ciclosporin A (CsA) is a fungal-derived cyclic undecapeptide with immunosuppressive properties.
• CsA affects non-immune cells, including epidermal and hair-follicle keratinocytes.
• Clinically, CsA is used for organ transplant rejection and shows efficacy in dermatoses like psoriasis.

Purpose:

• To explore the dermatological applications of Ciclosporin A.
• To understand the mechanism of action and side effects of CsA in treating skin conditions.
• To investigate the potential for developing effective topical formulations of CsA.

Summary:

• Ciclosporin A (CsA) exhibits immunosuppressive and keratinocyte-modulating effects, beneficial in psoriasis treatment.
• Systemic CsA use is associated with side effects, including nephrotoxicity, necessitating careful monitoring.
• Current topical CsA formulations have limited efficacy, driving research into improved delivery systems or analogues.

Impact:

• Highlights the dual role of CsA in both immune suppression and direct effects on skin cells.
• Underscores the clinical relevance of CsA in dermatology while acknowledging its safety concerns.
• Suggests future directions for topical CsA development to enhance therapeutic benefits and minimize systemic exposure.